Nasdaq Alec News Today

Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating on the […]

Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the […]

Euclidean Capital LLC lifted its stake in shares of Alector, Inc. (NASDAQ:ALEC – Free Report) by 33.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,307,858 shares of the company’s stock after purchasing an additional 326,964 shares during the period. Alector comprises about 1.8% of […]

Hsbc Holdings PLC grew its position in Alector, Inc. (NASDAQ:ALEC – Free Report) by 64.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 36,807 shares of the company’s stock after buying an additional 14,472 shares during the quarter. Hsbc Holdings PLC’s holdings in […]

Alector (NASDAQ:ALEC – Get Free Report) and Kodiak Sciences (NASDAQ:KOD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 69.7% of Alector shares […]

SOUTH SAN FRANCISCO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering...

Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have issued a buy recommendation on the […]

Stifel Nicolaus upgraded shares of Alector (NASDAQ:ALEC – Free Report) from a hold rating to a buy rating in a research note released on Thursday, Marketbeat Ratings reports. The firm currently has $15.00 price objective on the stock, up from their previous price objective of $8.00. ALEC has been the subject of a number of […]

Alector, Inc. (NASDAQ:ALEC – Get Free Report) saw a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 6,220,000 shares, a decrease of 13.0% from the November 15th total of 7,150,000 shares. Based on an average daily trading volume, of 710,100 shares, the days-to-cover ratio […]

Alector, Inc. (NASDAQ:ALEC – Get Free Report) CFO Marc Grasso sold 4,574 shares of the stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $5.56, for a total transaction of $25,431.44. Following the transaction, the chief financial officer now directly owns 150,673 shares of the company’s stock, […]